{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:21:34Z","timestamp":1785813694542,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82173253"],"award-info":[{"award-number":["No.82173253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10620-025-09386-0","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:01:37Z","timestamp":1757476897000},"page":"3356-3368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["EphA3\/EFNA3 Reverse Signalling Promotes Epithelial-to-Mesenchymal Transition via ERK Pathway to Facilitate Colorectal Cancer Metastasis"],"prefix":"10.1007","volume":"70","author":[{"given":"Ying","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"9386_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"9386_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA et al. Colorectal cancer. Lancet 2019;394:1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0.","journal-title":"Lancet"},{"key":"9386_CR3","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","volume":"25","author":"JS Tomlinson","year":"2007","unstructured":"Tomlinson JS, Jarnagin WR, Dematteo RP et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25:4575\u20134580. https:\/\/doi.org\/10.1200\/JCO.2007.11.0833.","journal-title":"J Clin Oncol"},{"key":"9386_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","volume":"24","author":"EB Pasquale","year":"2024","unstructured":"Pasquale EB. Eph receptors and ephrins in cancer progression. Nat Rev Cancer 2024;24:5\u201327. https:\/\/doi.org\/10.1038\/s41568-023-00634-x.","journal-title":"Nat Rev Cancer"},{"key":"9386_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jhep.2022.02.018","volume":"77","author":"A Husain","year":"2022","unstructured":"Husain A, Chiu YT, Sze KM et al. Ephrin-A3\/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. J Hepatol 2022;77:383\u2013396. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.018.","journal-title":"J Hepatol"},{"key":"9386_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/nn.2394","volume":"12","author":"A Filosa","year":"2009","unstructured":"Filosa A, Paixao S, Honsek SD et al. Neuron-glia communication via EphA4\/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci 2009;12:1285\u20131292. https:\/\/doi.org\/10.1038\/nn.2394.","journal-title":"Nat Neurosci"},{"key":"9386_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jnc.12819","volume":"131","author":"J Yang","year":"2014","unstructured":"Yang J, Luo X, Huang X et al. Ephrin-A3 reverse signaling regulates hippocampal neuronal damage and astrocytic glutamate transport after transient global ischemia. J Neurochem 2014;131:383\u2013394. https:\/\/doi.org\/10.1111\/jnc.12819.","journal-title":"J Neurochem"},{"key":"9386_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.4103\/1673-5374.301034","volume":"16","author":"RL Zhu","year":"2021","unstructured":"Zhu RL, Fang Y, Yu HH et al. Absence of ephrin-A2\/A3 increases retinal regenerative potential for Muller cells in Rhodopsin knockout mice. Neural Regen Res 2021;16:1317\u20131322. https:\/\/doi.org\/10.4103\/1673-5374.301034.","journal-title":"Neural Regen Res"},{"key":"9386_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.790947","volume":"10","author":"R Xie","year":"2022","unstructured":"Xie R, Yuan M, Jiang Y. The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer. Front Cell Dev Biol 2022;10:790947. https:\/\/doi.org\/10.3389\/fcell.2022.790947.","journal-title":"Front Cell Dev Biol"},{"key":"9386_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.21037\/tcr-22-979","volume":"11","author":"C Dong","year":"2022","unstructured":"Dong C, Li P, Wu Y et al. The 1q21.3 region driver gene EFNA3 promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis. Transl Cancer Res. 2022;11:1309\u20131320. https:\/\/doi.org\/10.21037\/tcr-22-979.","journal-title":"Transl Cancer Res."},{"key":"9386_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21873\/cgp.20300","volume":"19","author":"T Zadeh","year":"2022","unstructured":"Zadeh T, Lucero M, Kandpal RP. Artesunate-induced cellular effects are mediated by specific EPH receptors and ephrin ligands in breast carcinoma cells. Cancer Genomics Proteom. 2022;19:19\u201326. https:\/\/doi.org\/10.21873\/cgp.20300.","journal-title":"Cancer Genomics Proteom."},{"key":"9386_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.943384","volume":"9","author":"S Huang","year":"2022","unstructured":"Huang S, Dong C, Zhang J et al. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma. Front Mol Biosci. 2022;9:943384. https:\/\/doi.org\/10.3389\/fmolb.2022.943384.","journal-title":"Front Mol Biosci."},{"key":"9386_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.796592","volume":"12","author":"P Zheng","year":"2021","unstructured":"Zheng P, Liu X, Li H et al. EFNA3 is a prognostic biomarker correlated with immune cell infiltration and immune checkpoints in gastric cancer. Front Genet. 2021;12:796592. https:\/\/doi.org\/10.3389\/fgene.2021.796592.","journal-title":"Front Genet."},{"key":"9386_CR14","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.ymthe.2021.02.017","volume":"29","author":"T Chen","year":"2021","unstructured":"Chen T, Li K, Liu Z et al. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1alpha accumulation in Myc-dependent and independent pathways. Mol Ther. 2021;29:2134\u20132150. https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.017.","journal-title":"Mol Ther."},{"key":"9386_CR15","doi-asserted-by":"publisher","DOI":"10.3791\/50544","volume":"79","author":"SU Ahmed","year":"2013","unstructured":"Ahmed SU, Zair M, Chen K et al. Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice. J Vis Exp. 2013;79:e50544. https:\/\/doi.org\/10.3791\/50544.","journal-title":"J Vis Exp."},{"key":"9386_CR16","doi-asserted-by":"publisher","first-page":"e81445","DOI":"10.1371\/journal.pone.0081445","volume":"8","author":"G Falivelli","year":"2013","unstructured":"Falivelli G, Lisabeth EM, Rubio De La Torre E et al. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands. PLoS ONE 2013;8:e81445. https:\/\/doi.org\/10.1371\/journal.pone.0081445.","journal-title":"PLoS ONE"},{"key":"9386_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9\u201318. https:\/\/doi.org\/10.1038\/sj.cr.7290105.","journal-title":"Cell Res"},{"key":"9386_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/edrv.22.2.0428","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153\u2013183. https:\/\/doi.org\/10.1210\/edrv.22.2.0428.","journal-title":"Endocr Rev"},{"key":"9386_CR19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 2020;19:1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454.","journal-title":"Exp Ther Med"},{"key":"9386_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jhep.2022.03.008","volume":"77","author":"P Lin","year":"2022","unstructured":"Lin P, Yang H. EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma. J Hepatol 2022;77:879\u2013880. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.008.","journal-title":"J Hepatol"},{"key":"9386_CR21","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1111\/jcmm.15036","volume":"24","author":"L Wang","year":"2020","unstructured":"Wang L, Song Y, Wang H et al. MiR-210-3p-EphrinA3-PI3K\/AKT axis regulates the progression of oral cancer. J Cell Mol Med 2020;24:4011\u20134022. https:\/\/doi.org\/10.1111\/jcmm.15036.","journal-title":"J Cell Mol Med"},{"key":"9386_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12935-021-02226-x","volume":"21","author":"M Deng","year":"2021","unstructured":"Deng M, Tong R, Zhang Z et al. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma. Cancer Cell Int 2021;21:535. https:\/\/doi.org\/10.1186\/s12935-021-02226-x.","journal-title":"Cancer Cell Int"},{"key":"9386_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jcpa.2016.01.002","volume":"154","author":"G Hood","year":"2016","unstructured":"Hood G, Laufer-Amorim R, Fonseca-Alves CE et al. Overexpression of Ephrin A3 receptor in canine prostatic carcinoma. J Comp Pathol 2016;154:180\u2013185. https:\/\/doi.org\/10.1016\/j.jcpa.2016.01.002.","journal-title":"J Comp Pathol"},{"key":"9386_CR24","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3892\/or.2013.2679","volume":"30","author":"CY Lu","year":"2013","unstructured":"Lu CY, Yang ZX, Zhou L et al. High levels of EphA3 expression are associated with high invasive capacity and poor overall survival in hepatocellular carcinoma. Oncol Rep 2013;30:2179\u20132186. https:\/\/doi.org\/10.3892\/or.2013.2679.","journal-title":"Oncol Rep"},{"key":"9386_CR25","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3892\/or.2018.6586","volume":"40","author":"XY Lv","year":"2018","unstructured":"Lv XY, Wang J, Huang F et al. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells. Oncol Rep 2018;40:2408\u20132416. https:\/\/doi.org\/10.3892\/or.2018.6586.","journal-title":"Oncol Rep"},{"key":"9386_CR26","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1182\/blood.V94.7.2477.419k13_2477_2486","volume":"94","author":"M Dottori","year":"1999","unstructured":"Dottori M, Down M, Huttmann A et al. Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 1999;94:2477\u20132486.","journal-title":"Blood"},{"key":"9386_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/cbin.10974","volume":"42","author":"H Xiao","year":"2018","unstructured":"Xiao H, Yu L, Li F et al. MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer. Cell Biol Int 2018;42:1115\u20131123. https:\/\/doi.org\/10.1002\/cbin.10974.","journal-title":"Cell Biol Int"},{"key":"9386_CR28","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-18-0267","volume":"78","author":"MA Qazi","year":"2018","unstructured":"Qazi MA, Vora P, Venugopal C et al. Cotargeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma. Cancer Res. 2018;78:5023\u20135037. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0267.","journal-title":"Cancer Res."},{"key":"9386_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704\u2013715. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027.","journal-title":"Cell"},{"key":"9386_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15\u201333. https:\/\/doi.org\/10.1007\/s10555-008-9169-0.","journal-title":"Cancer Metastasis Rev."},{"key":"9386_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franci C et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84\u201389. https:\/\/doi.org\/10.1038\/35000034.","journal-title":"Nat Cell Biol."},{"key":"9386_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, Perez-Moreno MA, Rodrigo I et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76\u201383. https:\/\/doi.org\/10.1038\/35000025.","journal-title":"Nat Cell Biol."},{"key":"9386_CR33","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41467-019-10954-y","volume":"10","author":"R Brandt","year":"2019","unstructured":"Brandt R, Sell T, Luthen M et al. Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium. Nat Commun. 2019;10:2919. https:\/\/doi.org\/10.1038\/s41467-019-10954-y.","journal-title":"Nat Commun."},{"key":"9386_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/jcb.21889","volume":"105","author":"A Al-Ayoubi","year":"2008","unstructured":"Al-Ayoubi A, Tarcsafalvi A, Zheng H et al. ERK activation and nuclear signaling induced by the loss of cell\/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells. J Cell Biochem. 2008;105:875\u2013884. https:\/\/doi.org\/10.1002\/jcb.21889.","journal-title":"J Cell Biochem."},{"key":"9386_CR35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1349-7006.2010.01537.x","volume":"101","author":"JJ Yang","year":"2010","unstructured":"Yang JJ, Lee YJ, Hung HH et al. ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner. Cancer Sci. 2010;101:1374\u20131381. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01537.x.","journal-title":"Cancer Sci."},{"key":"9386_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40779-023-00501-8","volume":"10","author":"HJ Xiong","year":"2023","unstructured":"Xiong HJ, Yu HQ, Zhang J et al. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice. Mil Med Res. 2023;10:68. https:\/\/doi.org\/10.1186\/s40779-023-00501-8.","journal-title":"Mil Med Res."},{"key":"9386_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194600","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ren Z, Zheng D et al. AHSA1 promotes proliferation and EMT by regulating ERK\/CALD1 axis in hepatocellular carcinoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194600.","journal-title":"Cancers (Basel)"},{"key":"9386_CR38","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101330","author":"J Zheng","year":"2022","unstructured":"Zheng J, Shi Z, Yang P et al. ERK-Smurf1-RhoA signaling is critical for TGFbeta-drived EMT and tumor metastasis. Life Sci Alliance. 2022. https:\/\/doi.org\/10.26508\/lsa.202101330.","journal-title":"Life Sci Alliance"},{"key":"9386_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/cmi.2015.106","volume":"14","author":"S Li","year":"2017","unstructured":"Li S, Lu J, Chen Y et al. MCP-1-induced ERK\/GSK-3beta\/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells. Cell Mol Immunol 2017;14:621\u2013630. https:\/\/doi.org\/10.1038\/cmi.2015.106.","journal-title":"Cell Mol Immunol"},{"key":"9386_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-017-0629-4","volume":"16","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ou B, Han D et al. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK\/Elk-1\/Snail and AKT\/GSK3beta\/beta-catenin pathways. Mol Cancer 2017;16:70. https:\/\/doi.org\/10.1186\/s12943-017-0629-4.","journal-title":"Mol Cancer"},{"key":"9386_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrd4175","volume":"13","author":"AW Boyd","year":"2014","unstructured":"Boyd AW, Bartlett PF, Lackmann M. Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov 2014;13:39\u201362. https:\/\/doi.org\/10.1038\/nrd4175.","journal-title":"Nat Rev Drug Discov"},{"key":"9386_CR42","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.neuron.2008.07.032","volume":"59","author":"YS Lim","year":"2008","unstructured":"Lim YS, Mclaughlin T, Sung TC et al. p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 2008;59:746\u2013758. https:\/\/doi.org\/10.1016\/j.neuron.2008.07.032.","journal-title":"Neuron"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09386-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:21:24Z","timestamp":1760595684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09386-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9386"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09386-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}